Mon Health Medical Center is a 189-bed acute-care community hospital and Level IV Trauma Center located in Morgantown, West Virginia. It is part of Mon Health, an "integrated health care delivery system" serving north-central West Virginia, western Maryland, and southwestern Pennsylvania.

During the past decade, Monongalia Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 9 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 8 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Monongalia Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 9 trials, followed by "Boston Scientific Corporation" with 7 trials sponsored, "Gynecologic Oncology Group" with 4 trials sponsored, "GOG Foundation" with 2 trials sponsored and "NRG Oncology" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Monongalia Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator and "Milton S. Hershey Medical Center" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Monongalia Hospital" are "Recurrent Ovarian Carcinoma" (5 trials), "Recurrent Fallopian Tube Carcinoma" (4 trials), "Recurrent Primary Peritoneal Carcinoma" (4 trials), "Endometrial Serous Adenocarcinoma" (3 trials) and "Fallopian Tube Clear Cell Adenocarcinoma" (3 trials). Many other conditions were trialed in "Monongalia Hospital" in a lesser frequency.

Most popular intervention types in "Monongalia Hospital" are "Other" (17 trials), "Drug" (16 trials), "Biological" (9 trials), "Procedure" (8 trials) and "Device" (6 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (9 trials), "Laboratory Biomarker Analysis" (7 trials), "Questionnaire Administration" (7 trials), "Carboplatin" (5 trials) and "Computed Tomography" (4 trials). Other intervention names were less common.

The vast majority of trials in "Monongalia Hospital" are 14 trials for "Female" genders, 12 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Monongalia Hospital". undefined are not yet recruiting, 1 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Monongalia Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Monongalia Hospital, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".